Matt Swain has become a pioneer by pairing family offices looking to triple their money with under-the-radar businesses looking to exit.

Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...

Explore Gilead Sciences' Q3 2025 earnings: strong HIV portfolio growth, Yeztugo's rapid launch, and raised guidance.

Q3 2025 Earnings Call October 30, 2025 4:30 PM EDTCompany ParticipantsJacquie Ross - Senior Vice President of Treasury ...

Gilead Sciences said on Thursday its HIV drug sales rose 4% to $5.3 billion in the third quarter including $39 million for ...

Farmington-based UConn Health is warning thousands of patients with Aetna insurance coverage that they may lose their ...

This story was updated following CVS Health's earnings call Wednesday morning. | The company reported improvements in its ...

NEW YORK (Reuters) -CVS Health projected double-digit earnings growth for 2026 on Wednesday after raising its 2025 profit ...

CVS Health rode double-digit sales growth from drugstores and its pharmacy benefits management business to a better-than-expected third quarter. The health care giant also hiked its 2025 forecast ...

Rich Pavek retires after nearly 45 years with Cedar Valley Services, passing leadership to Garry Hart, who aims to continue ...

The Pharmacy & Consumer Wellness segment at CVS Health CVS is showing strong momentum, driven by the company’s focus on operational excellence and technological upgrades that improve the customer ...

Cigna will eliminate prescription drug rebates in many of its commercial health plans in 2027, upending a practice that’s ...